Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.

about

Identification of insertions in PTEN and TP53 in anaplastic thyroid carcinoma with angiogenic brain metastasis.

Item

http://www.wikidata.org/entity/Q36171837

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Identification of insertions i ...... h angiogenic brain metastasis.

@ast

Identification of insertions i ...... h angiogenic brain metastasis.

@en

type

Item

label

Identification of insertions i ...... h angiogenic brain metastasis.

@ast

Identification of insertions i ...... h angiogenic brain metastasis.

@en

prefLabel

Identification of insertions i ...... h angiogenic brain metastasis.

@ast

Identification of insertions i ...... h angiogenic brain metastasis.

@en

P1476

Identification of insertions i ...... th angiogenic brain metastasis

@en

P2093

Carmelo Nucera

http://www.w3.org/2001/XMLSchema#string

Derrick T Lin

http://www.w3.org/2001/XMLSchema#string

Dora Dias-Santagata

http://www.w3.org/2001/XMLSchema#string

Long Phi Le

http://www.w3.org/2001/XMLSchema#string

P2860

Integrated genomic characterization of papillary thyroid carcinoma

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.

Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.

Late intervention with anti-BRAF(V600E) therapy induces tumor regression in an orthotopic mouse model of human anaplastic thyroid cancer.

Orthotopic mouse models for the preclinical and translational study of targeted therapies against metastatic human thyroid carcinoma with BRAF(V600E) or wild-type BRAF

Thyroidectomy with neoadjuvant PLX4720 extends survival and decreases tumor burden in an orthotopic mouse model of anaplastic thyroid cancer.

Tenets of PTEN tumor suppression.

Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment

P304

L23-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1530/ERC-15-0198

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Zongli Zheng

Peter Sadow

P577

2015-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26472209

http://www.w3.org/2001/XMLSchema#string

P932

4609031

http://www.w3.org/2001/XMLSchema#string